Hit enter to search or ESC to close
No menu assigned
News
Plexium
Plexium Announces $102M Financing
FEBRUARY 23, 2022
Eikon Therapeutics
Eikon Therapeutics Announces $517.8 Million Series B Raise
JANUARY 6, 2022
Arbor Biotechnologies
Arbor Biotechnologies Closes $215 Million Oversubscribed Series B Financing
NOVEMBER 9, 2021
Entrada Therapeutics
Entrada Therapeutics Announces Pricing of Upsized Initial Public Offering
OCTOBER 28, 2021
ShouTi
ShouTi Secures $100 Million Series B Financing
OCTOBER 20, 2021
Obsidian
Obsidian Therapeutics Announces Closing of $115 Million Series B Financing
SEPTEMBER 9, 2021
Artios
Artios Announces $153 Million Series C Financing
JULY 27, 2021
RayzeBio
RayzeBio Secures $108 Million Series C Financing
JUNE 15, 2021
Synthekine
Synthekine Announces $107.5 Million Oversubscribed Series B Financing
JUNE 10, 2021
Affinia Therapeutics
Affinia Therapeutics Closes $110 Million Series B Financing
MAY 3, 2021
TCG X
TCG X Raises Inaugural $824 Million Fund to Advance Disruptive Medicines
APRIL 20, 2021
Entrada Therapeutics
Entrada Therapeutics Announces Closing of $116 Million Series B Financing
MARCH 31, 2021
Aktis Oncology
Aktis Oncology Announces $72 Million Series A Financing to Advance Breakthrough Radiopharmaceuticals
MARCH 18, 2021
Home
About Us
Our Team
Portfolio
News
Contact